Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (161-170 of 430) with videos related to

Pageof 43
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2012
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United StatesChristopher R Flowers, Stacey A Fedewa, Amy Y Chen, et al.
Leukemia & Lymphoma|March 11, 2017
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphomaJonathon B Cohen, Kami J Maddocks, Ying Huang, et al.
International Journal of Cancer|February 10, 2019
Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignanciesLauren R Teras, W Ryan Diver, Emily L Deubler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 29, 2012
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantationHongzheng Zhang, Michael Graiser, Donald A Hutcherson, et al.
Cancer|July 30, 2019
Patient and caregiver perceptions of lymphoma care and research opportunities: A qualitative studyJackelyn B Payne, Kaylin V Dance, Monique Farone, et al.
Infection Control and Hospital Epidemiology|March 24, 2017
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National StudyNishi N Shah, William McClellan, Christopher R Flowers, et al.
JAMA Oncology|August 28, 2015
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based CostDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
International Journal of Molecular Sciences|December 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case ReportChristopher Ronald Funk, Christopher T Petersen, Neera Jagirdar, et al.
British Journal of Haematology|May 26, 2017
Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment eraLi Tao, Christina A Clarke, Aaron S Rosenberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphomaAdam C Rose, Pareen J Shenoy, Gia Garrett, et al.
Pageof 43

Showing results (161-170 of 430) with videos related to

Sort By:
Pageof 43
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2012
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United StatesChristopher R Flowers, Stacey A Fedewa, Amy Y Chen, et al.
Leukemia & Lymphoma|March 11, 2017
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphomaJonathon B Cohen, Kami J Maddocks, Ying Huang, et al.
International Journal of Cancer|February 10, 2019
Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignanciesLauren R Teras, W Ryan Diver, Emily L Deubler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 29, 2012
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantationHongzheng Zhang, Michael Graiser, Donald A Hutcherson, et al.
Cancer|July 30, 2019
Patient and caregiver perceptions of lymphoma care and research opportunities: A qualitative studyJackelyn B Payne, Kaylin V Dance, Monique Farone, et al.
Infection Control and Hospital Epidemiology|March 24, 2017
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National StudyNishi N Shah, William McClellan, Christopher R Flowers, et al.
JAMA Oncology|August 28, 2015
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based CostDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
International Journal of Molecular Sciences|December 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case ReportChristopher Ronald Funk, Christopher T Petersen, Neera Jagirdar, et al.
British Journal of Haematology|May 26, 2017
Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment eraLi Tao, Christina A Clarke, Aaron S Rosenberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphomaAdam C Rose, Pareen J Shenoy, Gia Garrett, et al.
Pageof 43